Brief: Nervgen Says Co. Announces Pricing Of US$60.0 Million Public Offering Of Securities
22/05/2026 04:28
May 21 (Reuters) - NervGen Pharma Corp NGEN.O: NERVGEN ANNOUNCES PRICING OF US$60.0 MILLION PUBLIC OFFERING OF SECURITIES NERVGEN PHARMA CORP - COMMON SHARES SOLD AT $2.50 PER SHARE AND WARRANT Source text: ID:nGNX3QxnKl Further company coverage: NGEN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nervgen Pharma
See all newsBrief: Nervgen Announces First Participant Dosed In Restore, A Phase 3 Registrational Study Evaluating NVG-291 In Chronic Spinal Cord Injury
Brief: NervGen To Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
Brief: Nervgen Reports Second Quarter 2026 Financial Results And Provides Business Updates
Brief: Nervgen Pharma Corp - Nvg-291 Shows Statistically Significant Gait Quality Improvement In Phase 1B/2A Connect Sci Study
U.S. STOCKS ON THE MOVE-Sweetgreen, Dell Technologies, Peloton Interactive